Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -6.04% | +11.11% | +12.90% |
Apr. 23 | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
Apr. 16 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.90% | 293M | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.56% | 23.47B | |
-13.89% | 21.9B | |
-6.08% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Transcript : Akebia Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 11